K. O’Callaghan

发表

Improving the Safety and Effectiveness of Medical Device Therapy in Women.

D. Strauss, R. Zusterzeel, D. Marinac-Dabic, 2016, Journal of women's health.

Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.

David G. Strauss, William E. Sanders, I. Piña, 2014, JAMA internal medicine.

Engaging Patients Across the Spectrum of Medical Product Development: View From the US Food and Drug Administration.

R. Califf, Nina L. Hunter, K. O’Callaghan, 2015, JAMA.

Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: A Review of the Literature

D. Strauss, R. Zusterzeel, Changfu Wu, 2017, Cardiology in review.

Toward Sex-Specific Guidelines for Cardiac Resynchronization Therapy?

D. Strauss, R. Zusterzeel, F. Prinzen, 2016, Journal of Cardiovascular Translational Research.

The FDA Perspective on Heart Failure Devices

O. Faris, K. O’Callaghan, E. Chen, 2010 .

Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

I. Piña, D. Strauss, R. Zusterzeel, 2015, Journal of women's health.

Solutions for Disparities for Women with Heart Disease

K. O’Callaghan, 2009, Journal of cardiovascular translational research.

Sex‐Based Differences in Outcomes After Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report From TRANSLATE‐ACS

E. Peterson, P. Douglas, Tracy Y. Wang, 2014, Journal of the American Heart Association.

Gender- and race-based utilization and outcomes of pulmonary artery catheterization in the setting of full-time intensivist staffing

J. Panza, N. Cook, H. Cooper, 2012, Acute cardiac care.